Glucose Effectiveness in Obese Children: Relation to Degree of Obesity and Dysglycemia
Open Access
- 29 January 2015
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 38 (4) , 689-695
Abstract
OBJECTIVE Impaired glucose effectiveness (GE) plays a role in the deterioration of glucose metabolism. Our aim was to validate a surrogate of GE derived from an oral glucose tolerance test (OGTT) and to assess the impact of degrees of obesity and of glucose tolerance on it. RESEARCH DESIGN AND METHODS The OGTT-derived surrogate of GE (oGE) was validated in obese adolescents who underwent an OGTT and an intravenous glucose tolerance test (IVGTT). We then evaluated anthropometric determinants of the oGE and its impact on the dynamics of glucose tolerance in a cohort of children with varying degrees of obesity. RESULTS The correlation of oGE and IVGTT-derived GE in 98 obese adolescents was r = 0.35 (P < 0.001) as a whole and r = 0.51 (P < 0.001) in subjects with normal glucose tolerance. In a cohort of 1,418 children, the adjusted GE was associated with increasing obesity (P < 0.001 for each category of obesity). Quartiles of oGE and the oral disposition index were associated with 2-h glucose levels (P < 0.001 for both). Among 421 nondiabetic obese subjects (276 subjects with normal glucose tolerance/145 subjects with impaired glucose tolerance who repeated their OGTT after a mean time of 28 ± 16 months), oGE changes were tightly associated with weight (r = 0.83, P < 0.001) and waist circumference changes (r = 0.67, P < 0.001). Baseline oGE and changes in oGE over time emerged as significant predictors of the change in 2-h glucose levels (standardized B = −0.76 and B = −0.98 respectively, P < 0.001 for both). CONCLUSIONS The oGE is associated with the degree of and changes in weight and waist circumference and is an independent predictor of glucose tolerance dynamics.Keywords
Funding Information
- National Institute for Health Research (R01-HD-40787, R01-HD- 28016)
- National Center for Advancing Translational Sciences (DK045735)
- ADA Foundation (DK-49230)
This publication has 39 references indexed in Scilit:
- The Randle cycle revisited: a new head for an old hatAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- The regulation of glucose effectiveness: how glucose modulates its own productionCurrent Opinion in Clinical Nutrition and Metabolic Care, 2005
- Effects of GLP-1-(7–36)NH2, GLP-1-(7–37), and GLP-1- (9–36)NH2on Intravenous Glucose Tolerance and Glucose-Induced Insulin Secretion in Healthy HumansThe Journal of Clinical Endocrinology & Metabolism, 2003
- Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach.Diabetes, 1999
- Decreased glucose effectiveness but not insulin resistance in glucose-tolerant offspring of Japanese non—insulin-dependent diabetic patients: A minimal-model analysisMetabolism, 1997
- Impaired Basal Glucose Effectiveness in NIDDM: Contribution of Defects in Glucose Disappearance and Production, Measured Using an Optimized Minimal Model Independent ProtocolDiabetes, 1997
- Role of Glucose Effectiveness in the Determination of Glucose ToleranceDiabetes Care, 1996
- Insulin sensitivity, insulin secretion, and glucose effectiveness in subjects with impaired glucose tolerance: A minimal model analysisMetabolism, 1994
- Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.Journal of Clinical Investigation, 1994
- Assessment of Insulin Sensitivityin Vivo*Endocrine Reviews, 1985